Trial intelligence / Profile preview

Yellow fever vaccine effectiveness and safety in patients with rheumatic diseases

RBR-3875ddRecruiting

Sponsor
Hospital Universitário Cassiano Antônio de Moraes
Start
Jan 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of 17DD yellow fever vaccine in yellow fever (3 arms), sponsored by Hospital Universitário Cassiano Antônio de Moraes. Primary endpoints: Vaccine effectiveness and Vaccine safety. Started Jan 2017; status: recruiting.

02

Drugs

17DD yellow fever vaccine
03

Conditions

yellow fever

Beyond the preview

Go deeper on RBR-3875dd.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3875dd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call